STOCK TITAN

Christopher Sullivan to sell 18,606 shares (NASDAQ: AVTX) after option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting the proposed sale related to an exercise of stock options of 18,606 shares of Common stock on 05/07/2026 for cash. The filing also lists recent 10b5-1 sales by Christopher Sullivan totaling multiple transactions in April–May 2026, including a 47,000-share sale on 05/06/2026.

Positive

  • None.

Negative

  • None.

Insights

Rule 144 notice for option exercise and prior 10b5-1 executions; standard disclosure practice.

The filing lists an exercise of stock options that results in 18,606 shares being presented for sale on 05/07/2026 and records several recent 10b5-1 sales by Christopher Sullivan. The entries show dates, share counts, and gross proceeds for each transaction.

These entries are procedural: they notify the market of proposed sales under Rule 144 and document prior automatic sales under a 10b5-1 plan. Subsequent transaction settlement and Rule 144 eligibility depend on standard transfer and holding-period conditions; timing and final proceeds are not detailed here.

Proposed shares presented for sale 18,606 shares exercise of stock options on 05/07/2026
Proceeds shown (associated line item) $405,796.86 listed on same line as 18,606 shares (05/07/2026)
10b5-1 sale example 47,000 shares 10b5-1 sale on 05/06/2026 with proceeds $948,723.20
10b5-1 sale example 8,457 shares 10b5-1 sale on 04/30/2026 with proceeds $111,853.13
10b5-1 sale example 7,980 shares 10b5-1 sale on 04/02/2026 with proceeds $136,822.69
Form 144 regulatory
"submitted a Form 144 notice reporting the proposed sale"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 Sales regulatory
"10b5-1 Sales for CHRISTOPHER SULLIVAN"
Exercise of Stock Options financial
"Exercise of Stock Options | Issuer | Cash"
Issuer regulatory
"Exercise of Stock Options | Issuer | Cash"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Christopher Sullivan's Form 144 for AVTX report?

It reports a proposed sale tied to an option exercise of 18,606 shares on 05/07/2026. The filing also lists multiple prior 10b5-1 sales in April–May 2026 with share counts and gross proceeds.

Were there recent 10b5-1 sales by Christopher Sullivan for AVTX?

Yes. The filing lists several 10b5-1 sales, including a 47,000-share sale on 05/06/2026 with proceeds of $948,723.20, and smaller sales in April 2026 showing dates, shares, and gross proceeds.

Does the Form 144 state how proceeds will be used for AVTX?

No use-of-proceeds is stated. The entry for the 05/07/2026 transaction is labeled Cash, indicating a cash sale, but the filing does not specify any application of proceeds or recipient beyond the selling holder.

Does this Form 144 mean the shares have already been sold?

No. The Form 144 lists a proposed sale tied to an exercise of stock options on 05/07/2026. It separately documents prior completed 10b5-1 sales; the proposed sale's settlement and final disposition are not confirmed in this excerpt.